Extendicare (OTCMKTS:EXETF – Get Free Report) is expected to be announcing its results after the market closes on Thursday, November 5th. Analysts expect Extendicare to announce earnings of $0.25 per share and revenue of $446.58 million for the quarter.
Extendicare Stock Up 0.2%
Shares of EXETF opened at $19.17 on Tuesday. Extendicare has a 52-week low of $11.06 and a 52-week high of $28.45. The stock has a 50 day moving average price of $20.85 and a 200 day moving average price of $21.53.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on EXETF shares. Royal Bank Of Canada reissued an “outperform” rating on shares of Extendicare in a research report on Friday, August 14th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Extendicare in a report on Monday, October 26th. Five analysts have rated the stock with a Buy rating. According to data from MarketBeat, Extendicare currently has a consensus rating of “Buy”.
Check Out Our Latest Stock Report on EXETF
Extendicare Company Profile
Extendicare Inc is a Canadian provider of continuing health care and senior living services. The company operates long-term care homes and retirement communities, serving older adults who require residential care, assistance with daily living, or supportive housing.
Through its ParaMed business, Extendicare also provides home health-care services, including nursing, personal support, rehabilitation, and other care delivered in patients’ homes. In addition, the company offers management and consulting services to health-care and senior living operators through its Extendicare Assist platform.
Extendicare was established in 1968 and serves communities across Canada.
Recommended Stories
- Five stocks we like better than Extendicare
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
